本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Pasithea Therapeutics Corp.

1.69
-0.0400-2.31%
盘前1.720.0300+1.78%07:36 EDT
成交量:18.44万
成交额:32.04万
市值:457.19万
市盈率:-0.13
高:1.80
开:1.71
低:1.55
收:1.73
数据加载中...
2022/11/14

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/11/01

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/10/20

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/10/12

重要事件披露

8-K - Current report
2022/09/21

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2022/09/20

重要事件披露

8-K - Current report
2022/09/06

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/09/01

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/08/29

重要事件披露

8-K/A [Amend] - Current report
2022/08/15

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/08/11

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/07/28

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/06/29

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/06/27

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/06/27

重要事件披露

8-K/A [Amend] - Current report
2022/06/24

重要事件披露

8-K - Current report
2022/06/24

重要事件披露

8-K/A [Amend] - Current report
2022/06/22

重要事件披露

8-K - Current report
2022/06/16

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/06/10

重要事件披露

8-K - Current report